Advances in pharmacotherapy: Treatment of hypertensive crisis
Open Access
- 1 June 1994
- journal article
- research article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 19 (3), 163-180
- https://doi.org/10.1111/j.1365-2710.1994.tb00669.x
Abstract
A hypertensive crisis can be caused by many factors. Frequently, the mechanism involved is complex and highly variable among patients. Without drug therapy, this condition is associated with very high mortality and morbidity. There are a number of oral and intravenous hypotensive agents available, which can effectively control blood pressure in a hypertensive crisis. The relative advantages and disadvantages of each treatment option is discussed.Keywords
This publication has 85 references indexed in Scilit:
- Oral Labetalol Versus Oral Clonidine in the Emergency Treatment of Severe HypertensionThe American Journal of the Medical Sciences, 1992
- Clinical Pharmacokinetics of Drugs Administered Buccally and SublinguallyClinical Pharmacokinetics, 1991
- Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertensionAnnals of Emergency Medicine, 1991
- Dose‐Response Effect of Sublingual Captopril in Hypertensive CrisesThe Journal of Clinical Pharmacology, 1988
- Clinical Pharmacokinetics of ClonidineClinical Pharmacokinetics, 1988
- Current Management of Hypertensive EmergenciesDrugs, 1987
- Enalaprilat in Hypertensive EmergenciesThe Journal of Clinical Pharmacology, 1986
- Syncope and conduction disturbances following sublingual nifedipine for hypertensionAnnals of Emergency Medicine, 1985
- Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.Cell Metabolism, 1981
- Prolonged use of sodium nitroprussideThe Journal of Pediatrics, 1978